From Name:
From Email:
To Name:
To Email:

Optional Message:

Gilead to pay $11.9B for cancer treatment developer Kite

from ABC News

Gilead Sciences will pay $11.9 billion in cash to buy Kite Pharma and plant a stake in an emerging area of cancer treatments that train a patient's immune cells to attack tumors. Kite's portfolio of potential treatments includes one for the blood cancer lymphoma that could receive U.S. regulatory approval later this year. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063